Italy
· Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 799.75 million. The enterprise value is 749.05 million.
| Market Cap | 799.75M |
| Enterprise Value | 749.05M |
Important Dates
The last earnings date was Thursday, March 27, 2025.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Philogen has 40.29 million shares outstanding. The number of shares has decreased by -0.77% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 40.29M |
| Shares Change (YoY) | -0.77% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.54% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.13 |
| PS Ratio | 203.58 |
| PB Ratio | 10.55 |
| P/TBV Ratio | 10.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -25.52 |
| EV / Sales | 191.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -24.47 |
Financial Position
The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.18.
| Current Ratio | 5.22 |
| Quick Ratio | 4.98 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.45 |
| Interest Coverage | -67.87 |
Financial Efficiency
Return on equity (ROE) is -32.49% and return on invested capital (ROIC) is -19.81%.
| Return on Equity (ROE) | -32.49% |
| Return on Assets (ROA) | -17.35% |
| Return on Invested Capital (ROIC) | -19.81% |
| Return on Capital Employed (ROCE) | -36.81% |
| Revenue Per Employee | 22,523 |
| Profits Per Employee | -168,672 |
| Employee Count | 165 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 6.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.22% in the last 52 weeks. The beta is 0.12, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +12.22% |
| 50-Day Moving Average | 18.60 |
| 200-Day Moving Average | 19.74 |
| Relative Strength Index (RSI) | 62.67 |
| Average Volume (20 Days) | 10,564 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 3.92 million and -29.35 million in losses. Loss per share was -0.73.
| Revenue | 3.92M |
| Gross Profit | -14.99M |
| Operating Income | -33.26M |
| Pretax Income | -29.95M |
| Net Income | -29.35M |
| EBITDA | -30.52M |
| EBIT | -33.26M |
| Loss Per Share | -0.73 |
Balance Sheet
The company has 64.61 million in cash and 13.91 million in debt, giving a net cash position of 50.70 million or 1.26 per share.
| Cash & Cash Equivalents | 64.61M |
| Total Debt | 13.91M |
| Net Cash | 50.70M |
| Net Cash Per Share | 1.26 |
| Equity (Book Value) | 75.83M |
| Book Value Per Share | 1.88 |
| Working Capital | 60.89M |
Cash Flow
In the last 12 months, operating cash flow was -25.17 million and capital expenditures -5.45 million, giving a free cash flow of -30.62 million.
| Operating Cash Flow | -25.17M |
| Capital Expenditures | -5.45M |
| Free Cash Flow | -30.62M |
| FCF Per Share | -0.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | -848.61% |
| Pretax Margin | -764.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Philogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.77% |
| Shareholder Yield | 0.77% |
| Earnings Yield | -3.67% |
| FCF Yield | -3.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Philogen has an Altman Z-Score of 14.13.
| Altman Z-Score | 14.13 |
| Piotroski F-Score | n/a |